9999999997-15-008455.txt : 20150422
9999999997-15-008455.hdr.sgml : 20150422
20150422132415
ACCESSION NUMBER: 9999999997-15-008455
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20150422
DATE AS OF CHANGE: 20150422
20150422
20150422
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCA biopharma, Inc.
CENTRAL INDEX KEY: 0000907654
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 363855489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22873
FILM NUMBER: 15785109
BUSINESS ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
BUSINESS PHONE: 720-940-2200
MAIL ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
FORMER COMPANY:
FORMER CONFORMED NAME: NUVELO INC
DATE OF NAME CHANGE: 20030203
FORMER COMPANY:
FORMER CONFORMED NAME: HYSEQ INC
DATE OF NAME CHANGE: 19970610
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S
M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR
M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T
M:"`V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``+VHPRH@!&(61@X&I#%
MF*&8@:&1@9N!_9,R3*6("%1'&U@7@_)T")]1#B#``,/6!*H-"F5N9'-T7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@
M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;,"`P(#8Q,B`W.3)=
M+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]087)E;G0@."`P(%(O4F5S;W5R8V5S
M(#$V(#`@4B]2;W1A=&4@,"]4>7!E+U!A9V4^/@UE;F1O8FH-,3,@,"!O8FH-
M/#PO1FEL=&5R+T9L871E1&5C;V1E+T9II)-M:]LP$,>_RKW<7F1Z\(,<*(&D
MK;O!DH7:K(.0%VJB)08_!%MEZ;??2;(3SRP;;3AD67=_W9WLGU@(%)@`,086
M`?-P&H,G.'`*D>\#9\"H8'!S0^Z/^B'14BM\?TB8V47A<3(A<55J]*4I-YO1
MAZ]VIPLOZVJ3*+TBR[N8I.JHUY,)RK\MX:?,&X4O[!CS?=CB;55
M*`@B&'E4X/DH'ISR<&VCL2RR_/5#FA6J@87Z!8]5(K,GBZHN9&Y=3ZXE@1U]T3+/-M-RERN@)-&J^([?.73G,UK3
MR!H\/JI@?
M;7[25]DJ6(!]O3QKTU!:ORC;V:D]3+W5^V;%`PK&`NKFOIF8YWG@-$;QMS%<
M]4UPWC[-"$,!(6,@1&2'%XVMROC'2*75B>BT,PA"&W-9Z&GNK%<=E3YFH.W3
M>7B;R\P1GL/X.O59>;UASO6U`(=_`DS%^P#^+[O^!78C?AVZ[Z66TP&UG+V!
MVK,93LWX-[>75ATI?6XMK2U]AEI'35L)R74T1BW#'<=.-23U;(8Z4[$_FXS#
M3GA[1X:WK:O.>S%[5VC'X6\!!@!ZK)$C#0IE;F1S=')E86T-96YD;V)J#3$T
M(#`@;V)J#3P\+T9I;'1EJL+@2=;/ZYOB2]6[C`+8"%-@4A2S1,0M%
M\E)RL_F1?F^'%SFQ8FP3Q*9I\LS,F7-&^72[]>&I'=UDHT]9QL"';#_R&7CX
MBV^!%T/B3>@DA.QYY,$3_F6%>GD9$7"ROW'I^M2/()O;C>Q7NW`#FJ9OW[K4
M\_Q4W;:+E]$W\K!>90O'#6E*YK!UW(@F)'.H3Z:9V5W837#^S+Z,W)@F272)
MB1D:3+50F-O%[&&SRE8.G@X1`*;K.6"0@,;DC]GGZ?K6?H#9_=W=:KM=W:\-
M?$(G[]$59J#`7;O"FAF#Z5&*"IB'AU29C$[>53FDQ_49]<)!QCT+GF7A?C-?
M;.#6<2=8^6:ZSE;K6TQNO=19(4(88COZV\S>CIBYO9HO\,;T=\@VBVEVAQ\L
M67@QC@;UL)YW%3'[O(">+>1I8=F!Z2R#^R7X::#(9R2$/A'V'N]#K31":(S@^F$?/GQ3>'!):7R6B!7@19W.!$78%]N>
M=F9#=!TO(:\A/QXK4>2=:)P()5G#J2ZYA,T):V+ASF4@^?>3_HZWG:B?;&\O
M<_#/,F6!R:%HZKT3TH"(DM>=R!'!)Q5TDIME]^RD^(;?@3G7*$\D1(*H^PT?
M7Z4YIQ*L073`?Q0&RG'1G:>2&V6D-$!E>!\H,2WZ1DK8R\:4#MV!P^+'0>Q$
MUT+70`[+QO($ON=^A3TVM`2,9V5LP*_U\"Z7Q0%U.M9VI)?S9]`F?V"ZF[PU
M420_2MXB$[K(%G:O<-G!!"O%#O:5LO1:I8%MONYS=\@[?!&M8K,OSG#X_917
M8B]X"WEK"V1,8UYD&YX;FKXUU/:R@J)Y?N:R4,M&(E]U7NL/.IJ:>S%1,1G)
M3=*)FL3G"=(W1>=C]*9ZLI2%3L$TQ>F13>&OC7)QQ&O>2`1/-`M
MG5&((O9(=H_.(PD?G;$.-!?_B%9!:7,&E+W1&9WIU"B8Q:R1QT::T$M=*(<#
M4E?RCB.Q!B$-WK5D.+)%C7VNFTYI[7C:H=VJ5RA%6U1-R\V080GU@^L2$QT%
MK+EH9(GNJU['R@(5"K_L>VM2"))W*4S.*4P,U29_ZX'8>?5%7SHBS-C1L>
M2?OHF(9A26]H9RWX9H["BZ@J7=&.HWHKKI6,U2G4OAXV>)+Y9VK52N5DN-#V
MC[3;(Z*$X,2XX-`)Y?P`5T^0X"`)2.&K(&!!AMLK?C#S0
MB<-QGE[Q9#_354YV+N`#_[G."R3F9T63&ZE&_Q>*
M"?*J;/O+YY%F8V]Y(7F7RU?]!#*A%]GH/P$&`*K*CLP-"F5N9'-T,E,P4#!7,+10
ML+'1]RO-+8X&<0T4@F+M[(`BP?HN=G8``08`C84(-PT*96YDFMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O"UN"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M($%2
M0T%B:6]P:&%R;6$S,C(Y,F=R86YT+D9)3F]K/"]R9&8Z;&D^"B`@("`@("`@
M("`@(#PO&UP.D-R96%T;W)4;V]L/@H@("`@("`@("`\>&UP.DUO9&EF>41A=&4^
M,C`Q-2TP-"TR,E0Q,SHQ.3HS-"TP-#HP,#PO>&UP.DUO9&EF>41A=&4^"B`@
M("`@(#PO&UP34TZ26YS=&%N8V5)1#YU=6ED.C9A9&0S-&$Y+34V-3(M-&1C,BTY-6(X
M+38V,C,T-3`Q-#0Y9CPO>&UP34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z
M1&5S8W)I<'1I;VX^"B`@(#POJ'5!:DZ@?,RQ;L(P$(#A5[D->\"QG61(A9`"":A208@B6%A,[!:K;@Y=#O'Z9&!F
M_[^_`@VS65;?^8HDOMICNUVT^_5!9DL*CB/VC>,@F@^K3:D+:TUNJKR8ZF*B
M]>15C7+WW5&\<:E\2G`,-(P22F65E=D&_?O)CM#?NT"B[@@OCJ&)`\>4`H'1
MRBB3PUF<8N_Q,9RES`Z14Q";.-8#_C"PON9[5
MZG.+?W(^?PHP`)^C1J,-"F5N9'-TF4@,3`O5'EP92]84F5F
M+U=;,2`R(#%=/CYS=')E86T-"FC>8F(``B9&KE0&)@:&-B#!7P!B]0())CF@
MQ-/?("X#(Y!@^@\D&!D``@P`<)\%&PT*96YD